Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Pharmacokinetic and Safety Profile of the Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV
Antimicrobial Agents and Chemotherapy  (IF5.191),  Pub Date : 2021-09-13, DOI: 10.1128/aac.00935-21
Wendy Ankrom, Deanne Jackson Rudd, Andrea Schaeffer, Deborah Panebianco, Evan J. Friedman, Charles Tomek, S. Aubrey Stoch, Marian Iwamoto

MK-8507 is a novel HIV-1 non-nucleoside reverse transcriptase inhibitor in clinical development with potential for once-weekly oral administration for the treatment of HIV-1 infection. Two randomized, double-blind, placebo-controlled phase 1 studies in ...